CDXS Codexis Bio: Wutah dodolan triwulanan

Simbol resmi perusahaan Codexis, Inc. (CDXS)

Minimizing capital expenditures through the outsourcing of protein production creates growth potential, which is confirmed by the increase in quarterly revenue for Codexis, Inc. (CDXS). The 124.40 level captures the latest values of this metric. However, revenues based on enzyme licensing and the execution risks of the ECO Synthesis platform R&D pipeline necessitate caution, as any deviations in sales dynamics could signal a forthcoming asset revaluation.

CDXS (Codexis Bio) riwayat Wutah dodolan triwulanan saka 04.07.2022 nganti 19.11.2026

Rincian metrik keuangan lan pasar Codexis, Inc. (CDXS)

- rega saham lan target rega konsensus:
- data kapitalisasi saham perusahaan:
Analisis fundamental perusahaan:Codexis, Inc. (CDXS)
Barang unggulan Codexis Bio

Codexis, Inc. (CDXS) generates profit from licensing unique enzymes and selling specialized proteins for the pharmaceutical sector. This indicator calculates the percentage deviation of current revenue from the previous quarter's figures, capturing the expansion rate of commercial activities. For the investor, the value of 124.40 serves as a marker for the scaling of partnership agreements and market demand. Analyzing the change in sales volume per quarter allows for the timely detection of fundamental shifts in business trends.

Pesaing langsung

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Wutah pendapatan triwulanan ultragenyx.com (RARE)|Wutah pendapatan triwulanan BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Tingkat wutah pendapatan sajrone kuartal|twistbioscience.com - Wutah pendapatan triwulanan|10x Genomics, Inc. - Owah-owahan dodolan kuartal marang kuartal|NTLA (Intellia Corp) - Wutah dodolan triwulanan|Wutah dodolan triwulanan stoketherapeutics.com|Wutah dodolan triwulanan BLFS|Wutah dodolan triwulanan Wave Life Sciences Corp (WVE)|Wutah pendapatan triwulanan MAZE|Tingkat wutah dodolan sajrone kuartal Sionna Therapeutics Inc|Wutah pendapatan kuartal marang kuartal Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Tingkat wutah pendapatan sajrone kuartal|QURE - Wutah pendapatan kuartal marang kuartal|MeiraGTx Holdings (MGTX) - Wutah dodolan triwulanan|Regenxbio (RGNX) - Wutah pendapatan kuartal marang kuartal|SLDB - Tingkat wutah dodolan sajrone kuartal|OCGN (Ocugen Inc) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal PACB|Wutah pendapatan kuartal marang kuartal Benitec (BNTC)|Design Therapeutics Inc - Wutah dodolan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Rocket Pharma RCKT|Wutah pendapatan triwulanan 4DMT FDMT|LXEO - Wutah pendapatan kuartal marang kuartal|Tingkat wutah pendapatan sajrone kuartal Korro Bio Inc.|EDIT: Wutah pendapatan triwulanan|SLN - Tingkat wutah dodolan sajrone kuartal|PRQR (ProQR Therapeutics) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)